Mycophenolate mofetil treatment of crescentic Henoch-Schnlein nephritis with IgA depositions

Dede F., Onec B., Ayli D., IŞIK GÖNÜL İ., Onec K.

SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, vol.42, no.2, pp.178-180, 2008 (SCI-Expanded) identifier identifier identifier


Mycophenolate mofetil (MMF) is considered to be a promising therapeutic agent in primary glomerulonephritis but there are no data on the use of MMF in Henoch-Schonlein nephritis (HSN). Herein we report the first adult crescentic HSN patient in whom long-term complete remission was achieved after MMF therapy.